This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.

Launch Date: May 2, 2024

Release Date: May 2, 2024

Expiration Date: April 30, 2025

FACULTY BIO

Jesús G. Berdeja, MD

Director of Multiple Myeloma Research

The Greco-Hainsworth Tennessee Oncology Centers for Research

Joseph Mikhael, MD, MEd, FRCPC, FAC ...